ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas
about
Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma.Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway.Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinomaAnti-EGFR Agents: Current Status, Forecasts and Future Directions.Tissue-scale coordination of cellular behaviour promotes epidermal wound repair in live mice.A genetic cell context-dependent role for ZEB1 in lung cancer.Autophosphorylation of the C-terminal domain is not required for oncogenic transformation by lung-cancer derived EGFR mutants.
P2860
Q35774120-391C2DB6-E70A-468A-A177-6CA07FAF4A78Q37529089-DBB57718-660E-4347-BA47-B4EBE6B88A86Q38821915-A2EFC8F7-01A5-4250-A311-CBCD6F89B4B5Q38832105-C7B795BB-DDE4-49D9-B57E-C7FAD0A97FFCQ41594189-F88863B1-7790-4476-9616-63FF52B4DA3AQ42399000-E2EA76E2-5E76-4FC2-B3DE-CF96A2E3E013Q49720489-E8A48D35-F81D-4747-9412-66671DFCF76A
P2860
ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas
@en
type
label
ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas
@en
prefLabel
ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas
@en
P2093
P2860
P50
P1433
P1476
ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas
@en
P2093
Amlak Bantikassegn
Pang-Dian Fan
Udayan Guha
Xiaoling Song
P2860
P304
P356
10.1158/0008-5472.CAN-13-1625
P407
P577
2015-01-16T00:00:00Z